Current Issue | New England Journal of Medicine
Explore the current issue of The New England Journal of Medicine (Vol. 390 No. 19).
Explore the current issue of The New England Journal of Medicine (Vol. 390 No. 19).
Alteplase is the standard agent used in early reperfusion therapy, but alternative thrombolytic agents are needed. The efficacy and safety of reteplase as compared with…
Tenecteplase is an effective thrombolytic agent for eligible patients with stroke who are treated within 4.5 hours after the onset of stroke. However, data regarding…
The Inclusive Dermatology Atlas from the University of New Mexico was designed to address disparities in diagnostic accuracy and thereby reduce disease burden, especially among…
The risk of second tumors after chimeric antigen receptor (CAR) T-cell therapy, especially the risk of T-cell neoplasms related to viral vector integration, is an…
Anti-amyloid antibody administration decreased plaque volume in clinical trials of patients with early AD, indicating that passive immunotherapies could be a promising treatment for the…
In this program, a panel of experts in the management of diabetes educate healthcare providers on teplizumab’s role in delaying type 1 diabetes stage progression…
Influenza A(H5N1) virus has been identified in dairy herds and in the commercial milk supply. In this report, inactivation of the virus in milk by…
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
A 51-year-old woman presented with a 2-month history of dyspnea. A chest radiograph showed pleural effusions, and CT of the pelvis showed a pelvic mass…
The Disability Ingetration Toolkit was developed at SUNY Upstate to help educators enhance medical students’ knowledge, skills, and cultural competencies regarding the care of people…